Long-anticipated changes to California’s Proposition 65 warning requirements took effect on August 30, 2018, through amendments and new rules issued by the California Office of Environmental Health Hazard Assessment.
President Trump is expected to sign into law a bill which will – among other things – expand the scope of the Open Payments reporting requirements mandated by Section 6002 of the Patient Protection and Affordable Care Act (often referred to as the Sunshine Act).
On September 28, 2018, the Pharmaceutical Research and Manufacturers of America (PhRMA) filed an amended complaint to revive its lawsuit seeking to block implementation and enforcement of California’s drug price transparency law.
In the last hour of the last day of last month, with 30 minutes to spare, US Trade Representative Lighthizer met the US self-imposed deadline and formally sent to Congress the agreed-upon text of a US-Mexico-Canada Agreement, or USMCA.
Last week, the Drug Enforcement Agency (DEA) published in the Federal Register its Final Order placing FDA-approved cannabidiol drug products (CBD) containing no more than 0.1 percent tetrahydrocannabinols in schedule V of the Controlled Substances Act.
California Gov. Jerry Brown, in a surprise move, vetoed a wide-ranging bill backed by the California New Car Dealers Association over his concerns regarding a formula automakers would have had to use to pay dealers for warranty and recall repairs.
US Customs and Border Protection’s Executive Assistant Commissioner of Field Operations, Todd Owen, recently spoke with Politico and confirmed that CBP will continue to apply long-standing US federal laws and regulations that treat marijuana as a banned substance at the US border.
Starting on January 1, 2020, fashion and retail companies from around the world will need to comply with the strongest online privacy law in the United States, the California Consumer Privacy Act of 2018.
Arent Fox is pleased to announce the launch of the Investigations Blog, a dedicated resource for legal updates and analysis on key enforcement news for companies and executives in highly regulated industries.
The Trump Administration recently announced several major decisions, including: finalizing the List 3 products subject to additional duties and revealing its implementation schedule.
As if their litigation problems weren’t enough, Germany’s beleaguered car industry faces another regulatory tangle, as the European Union opened a probe into Volkswagen AG, Daimler AG and BMWAG over suspected collusion that could have delayed clean-emissions technology for cars.
A federal district court vacated in its entirety the Centers for Medicare and Medicaid Services’ (CMS) regulations regarding the reporting and returning of overpayments by Medicare Advantage plan insurers.
On September 11, 2018, hospital advocacy groups and three individual hospitals filed a complaint in the United States District Court for the District of Columbia.
The National Labor Relations Board (NLRB or Board) published a Notice of Proposed Rulemaking in the Federal Register on September 14, 2018 regarding its controversial joint-employer standard.